跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPCLUSA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EPCLUSA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
EPCLUSA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Gilead Sciences Ireland Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 29, 2025
Approval ID
2526c7cd58ccb3c0
Company
Gilead Sciences Ireland Unlimited Company
Type
Standard
Approval Details
Approval Id
2526c7cd58ccb3c0
Drug Cima Aemps Name
EPCLUSA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1161116001IP1
Holder Company Name
Gilead Sciences Ireland Unlimited Company
Marketing Company Name
Orifarm A/S
Holder Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Authorization Date
2025-08-29
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg/100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Gilead Sciences Ireland Unlimited Company
Company Detail Path
/organization/gilead-sciences-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
GILEAD SCIENCES IRELAND UNLIMITED COMPANY
Country Name
Ireland
City Name
carrigtwohill,country_ie
Address
Ida Business & Technology Park
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 29, 2025
Approval ID
2526c7cd58ccb3c0
Type
Standard
Back to CIMA-AEMPS Approvals